Our Vision

To bridge the gap between molecular discovery and clinical safety in modern medicine. Our research focuses on protecting the cardiovascular system from therapeutic harm and chronic disease—whether that means mitigating endothelial damage caused by chemotherapy, mapping how metabolic therapies alter drug metabolism, or targeting monocyte–endothelial interactions to disrupt the progression of atherosclerosis. We strive to deliver the mechanistic insights necessary to anticipate drug interactions and preserve vascular integrity in an era of complex polypharmacy.